vimarsana.com

Page 8 - ஐரோப்பிய தொழிற்சங்கம் நல்ல உற்பத்தி ப்ர்யாக்டிஸஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investorideas com - Investor Ideas Potcasts #541, Cannabis News and Stocks on the Move; (TSXV: KHRN) (TSX: VIVO) (TSX: VLNS) (OTCQX: VLNCF) (TSXV: PCLO)

Clever Leaves Receives Largest 2021 Production Quotas from the Colombian Government Clever Leaves quota represents 50% of the total quota for Colombia and approximately 18% of the world s legal production quota of medical cannabis

NEW YORK, March 02, 2021 (GLOBE NEWSWIRE) Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today announced that the Colombian Technical Quotas Group (“TQG”) authorized Clever Leaves’ Colombian operations to manufacture up to approximately 59,000 kilograms of cannabis into dried flower derivatives. According to the International Narcotics Control Board’s publicly disclosed data, Clever Leaves’ total allocation represents 50% of Colombia’s total quota and approximately 18% of the world’s legal medical cannabis production quota for 2021. The new 2021 production quota authorizes Clever Leaves to extract medical cannabis and the total quantity allocated to their company is forecasted to be sufficient towards meeting the aggregate international demand for Clever Leaves’ products. To date, Clever Leaves has successfully exported to m

Clever Leaves Receives Largest 2021 Production Quotas from the Colombian Government

Clever Leaves Receives Largest 2021 Production Quotas from the Colombian Government Clever Leaves’ quota represents 50% of the total quota for Colombia and approximately 18% of the world’s legal production quota of medical cannabis March 02, 2021 08:00 ET | Source: Clever Leaves Clever Leaves NEW YORK, March 02, 2021 (GLOBE NEWSWIRE) Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today announced that the Colombian Technical Quotas Group ( TQG ) authorized Clever Leaves’ Colombian operations to manufacture up to approximately 59,000 kilograms of cannabis into dried flower derivatives. According to the International Narcotics Control Board’s publicly disclosed data, Clever Leaves’ total allocation represents 50% of Colombia’s total quota and approximately 18% of the world’s legal

Aphria and Tilray Announce Launch of www aphriatilraytogether com

Anti-Trust Clearances Received and Transaction Remains On-Track to Close in the Second Quarter of 2021 LEAMINGTON, ON and NANAIMO, BC, Feb. 23, 2021 /PRNewswire/ - Aphria Inc. ( Aphria ) (TSX: APHA andNASDAQ: APHA), a leading global cannabis-lifestyle consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, and Tilray, Inc. ( Tilray ) (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, are pleased to announce the launch of the website: www.aphriatilraytogether.com. This new, dedicated resource seeks to provide  shareholders of both companies with pertinent information, news and updates leading up to the special meetings of shareholders at which Aphria s and Tilray s respective shareholders will vote on the resolutions necessary to implement the proposed business combination of the two companies (the

Clever Leaves Strengthens Leadership Team and Appoints Hank Hague as Chief Financial Officer

Clever Leaves Strengthens Leadership Team and Appoints Hank Hague as Chief Financial Officer Nachrichtenquelle: globenewswire  |  22.02.2021, 14:00  |  130   |  0  NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced today the appointment of Hank Hague as its new Chief Financial Officer, effective immediately. Mr. Hague joins Clever Leaves with extensive experience in providing financial leadership to various public and private entities in the pharmaceutical, biomedical, and cannabis industries. Most recently, Mr. Hague served as CEO at Aidance Scientific, an FDA-registered manufacturer of branded and private label OTC topical medications. Prior to this r

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.